Hypermethylated RASSF1A in Maternal Plasma: A Universal Fetal DNA Marker that Improves the Reliability of Noninvasive Prenatal Diagnosis

作者: KC Allen Chan , Chunming Ding , Ageliki Gerovassili , Sze W Yeung , Rossa WK Chiu

DOI: 10.1373/CLINCHEM.2006.074997

关键词:

摘要: Background: We recently demonstrated that the promoter of RASSF1A gene is hypermethylated in placenta and hypomethylated maternal blood cells. This methylation pattern allows use methylation-sensitive restriction enzyme digestion for detecting placental-derived sequences plasma. Methods: performed real-time PCR after to detect plasma 28 1st-trimester 43 3rd-trimester pregnant women. used perform prenatal fetal rhesus D (RhD) group typing 54 early-gestation RhD-negative women, with as positive control DNA detection. Results: Hypermethylated were detectable all 71 The genotype was identical each case, thus confirming its origin. Nineteen women undergoing RhD genotyping showed undetectable RHD their samples. control, , not 4 19 Subsequent chorionic villus sample analysis revealed 2 these negative signals fact carrying RhD-positive fetuses. Conclusions: a universal marker readily plasma. When applied genotyping, this detection false-negative results caused by low concentrations new can also be many other diagnostic monitoring scenarios.

参考文章(15)
Xiao Yan Zhong, Martin R. B�rk, Carolyn Troeger, Laird R. Jackson, Wolfgang Holzgreve, Sinuhe Hahn, Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses Prenatal Diagnosis. ,vol. 20, pp. 795- 798 ,(2000) , 10.1002/1097-0223(200010)20:10<795::AID-PD897>3.0.CO;2-P
Diana W. Bianchi, Neil D. Avent, Jean-Marc Costa, C Ellen van der Schoot, Noninvasive Prenatal Diagnosis of Fetal Rhesus D: Ready for Prime(r) Time Obstetrics & Gynecology. ,vol. 106, pp. 841- 844 ,(2005) , 10.1097/01.AOG.0000179477.59385.93
Christoph Grunau, SJ Clark, André Rosenthal, Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Research. ,vol. 29, pp. 65- ,(2001) , 10.1093/NAR/29.13.E65
Richard J Levine, Cong Qian, Erik S LeShane, Kai F Yu, Lucinda J England, Enrique F Schisterman, Tuangsit Wataganara, Roberto Romero, Diana W Bianchi, Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia American Journal of Obstetrics and Gynecology. ,vol. 190, pp. 707- 713 ,(2004) , 10.1016/J.AJOG.2003.12.019
S. S. C. Chim, Y. K. Tong, R. W. K. Chiu, T. K. Lau, T. N. Leung, L. Y. S. Chan, C. B. M. Oudejans, C. Ding, Y. M. D. Lo, Detection of the placental epigenetic signature of the maspin gene in maternal plasma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 14753- 14758 ,(2005) , 10.1073/PNAS.0503335102
Rossa W K Chiu, Leo L M Poon, Tze K Lau, Tse N Leung, Eric M C Wong, Y M Dennis Lo, Effects of Blood-Processing Protocols on Fetal and Total DNA Quantification in Maternal Plasma Clinical Chemistry. ,vol. 47, pp. 1607- 1613 ,(2001) , 10.1093/CLINCHEM/47.9.1607
YM Dennis Lo, Tze K Lau, Jun Zhang, Tse N Leung, Allan MZ Chang, N Magnus Hjelm, R Sarah Elmes, Diana W Bianchi, Increased Fetal DNA Concentrations in the Plasma of Pregnant Women Carrying Fetuses with Trisomy 21 Clinical Chemistry. ,vol. 45, pp. 1747- 1751 ,(1999) , 10.1093/CLINCHEM/45.10.1747
Lan Zhou, John A. Thorson, Clark Nugent, Robertson D. Davenport, Suzanne H. Butch, W. John Judd, Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women American Journal of Obstetrics and Gynecology. ,vol. 193, pp. 1966- 1971 ,(2005) , 10.1016/J.AJOG.2005.04.052
Rossa WK Chiu, Tze K Lau, Tse N Leung, Katherine CK Chow, David HK Chui, YM Dennis Lo, Prenatal exclusion of β thalassaemia major by examination of maternal plasma The Lancet. ,vol. 360, pp. 998- 1000 ,(2002) , 10.1016/S0140-6736(02)11086-5
Y.M. Dennis Lo, N. Magnus Hjelm, Carrie Fidler, Ian L. Sargent, Michael F. Murphy, Paul F. Chamberlain, Priscilla M.K. Poon, Christopher W.G. Redman, James S. Wainscoat, Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. The New England Journal of Medicine. ,vol. 339, pp. 1734- 1738 ,(1998) , 10.1056/NEJM199812103392402